# ctDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI)

> **NCT06813664** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 60 (estimated)

## Conditions studied

- Metastatic NSCLC - Non-Small Cell Lung Cancer
- OligoProgressive Metastatic Disease

## Interventions

- **RADIATION:** Radiotherapy
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT06813664
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2028-04-01
- **Final completion:** 2028-04-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06813664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06813664, "ctDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06813664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*